Clinical features of spinal cord sarcoidosis: Analysis of 17 neurosarcoidosis patients

Journal of Neurology

Volumn 258, Issue 12, 2011, Pages 2163-2167

  Sakushima, Ken ^a   Yabe, Ichiro ^a   Nakano, Fumihito ^b   Yoshida, Kazuto ^b   Tajima, Yasutaka ^c   Houzen, Hideki ^d   Maruo, Yasunori ^e   Sasaki, Hidenao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ASAHIKAWA RED CROSS HOSPITAL   (Japan)

^c SAPPORO CITY GENERAL HOSPITAL   (Japan)

^d Obihiro Kosei General Hospital   (Japan)

^e Hakodate Municipal Hospital   (Japan)

Author keywords

Angiotensin converting enzyme; Cerebrospinal fluid; Neurosarcoidosis; Spinal cord sarcoidosis

Indexed keywords

CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; METHOTREXATE;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CRANIAL NERVE; FEMALE; GENERAL HOSPITAL; HUMAN; LEUKOCYTOSIS; MALE; MENINGITIS; NERVE LESION; NERVE ROOT INJURY; PRIORITY JOURNAL; SARCOIDOSIS; SPINAL CORD LESION;

ADRENAL CORTEX HORMONES; ADULT; AGE OF ONSET; AGED; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RETROSPECTIVE STUDIES; SARCOIDOSIS; SPINAL CORD DISEASES; YOUNG ADULT;

EID: 83255185718     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6080-3     Document Type: Article

References (18)

1. RP Baughman AS Teirstein MA Judson MD Rossman H Yeager Jr EA Bresnitz L DePalo G Hunninghake MC Iannuzzi CJ Johns G McLennan DR Moller LS Newman DL Rabin C Rose B Rybicki SE Weinberger ML Terrin GL Knatterud R Cherniak 2001 Clinical characteristics of patients in a case control study of sarcoidosis Am J Respir Crit Care Med 164 1885 1889 11734441 1:STN:280:DC%2BD38%2FlsVGjug%3D%3D (Pubitemid 33152325)
2. JP Zajicek NJ Scolding O Foster M Rovaris J Evanson IF Moseley JW Scadding EJ Thompson V Chamoun DH Miller WI McDonald D Mitchell 1999 Central nervous system sarcoidosis-diagnosis and management QJM 92 103 117 10209662 10.1093/qjmed/92.2.103 1:STN:280:DyaK1M3is1WgtQ%3D%3D (Pubitemid 29097635)
3. FG Joseph NJ Scolding 2007 Sarcoidosis of the nervous system Pract Neurol 7 234 244 17636138 10.1136/jnnp.2007.124263 1:STN:280:DC%2BD2svlsVGjsA%3D%3D (Pubitemid 47193707)
4. S Saleh C Saw K Marzouk O Sharma 2006 Sarcoidosis of the spinal cord: literature review and report of eight cases J Natl Med Assoc 98 965 976 16775923
5. L Varron C Broussolle JP Candessanche R Marignier H Rousset J Ninet P Seve 2009 Spinal cord sarcoidosis: report of seven cases Eur J Neurol 16 289 296 19170748 10.1111/j.1468-1331.2008.02409.x 1:STN:280:DC%2BD1M3nsVemsg%3D%3D
6. H Ozawa T Sato H Hyodo Y Ishii N Morozumi Y Koizumi F Matsumoto F Kasama T Aizawa E Itoi S Kokubun 2009 Clinical significance of intramedullary Gd-DTPA enhancement in cervical myelopathy Spinal Cord 48 415 422 19901954 10.1038/sc.2009.152
7. K Oe M Doita H Miyamoto F Kanda M Kurosaka M Sumi 2009 Is extensive cervical laminoplasty an effective treatment for spinal cord sarcoidosis combined with cervical spondylosis? Eur Spine J 18 570 576 19214600 10.1007/s00586-009-0891-2
8. BA Rybicki M Major J Popovich Jr MJ Maliarik MC Iannuzzi 1997 Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization Am J Epidemiol 145 234 241 9012596 1:STN:280:DyaK2s7msVygtg%3D%3D
9. K Ota T Tsunemi K Saito F Yamanami M Watanabe T Irioka H Mizusawa 2009 (18)F-FDG PET successfully detects spinal cord sarcoidosis J Neurol 256 11 1943 1946 19685103 10.1007/s00415-009-5270-8
10. I Takahashi H Soma K Sakushima S Tsuji-Akimoto M Niino I Yabe H Sasaki 2010 Cervical intramedullary sarcoidosis diagnosed after laminoplasty for spondylosis Shinkei Chiryogaku (Neurological Therapeutics) 27 209 213
11. M Matsushima Y Miyazaki T Kano S Tsuji H Sasaki 2006 Central nervous system sarcoidosis with extensive cerebral edema ShinkeiNaika (Neurological Medicine) 64 314 316
12. K Sakushima M Niino I Yabe S Akimoto-Tsuji H Sasaki 2009 Weakness and sensory disturbance of the left extremities J Clin Neurosci 16 1608 1711 20468080 10.1016/j.jocn.2008.12.017
13. Sakushima K, Yabe I, Shiga T, Yashima-Yamada M, Tsuji-Akimoto S, Terae S, Sasaki H (2011) FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis. J Neurol 258:227-230
14. T Morimoto A Azuma S Abe J Usuki S Kudoh K Sugisaki M Oritsu T Nukiwa 2008 Epidemiology of sarcoidosis in Japan Eur Respir J 31 372 379 17959635 10.1183/09031936.00075307 1:STN:280:DC%2BD1c%2FnvV2jug%3D%3D
15. F Cohen-Aubart D Galanaud D Grabli J Haroche Z Amoura C Chapelon-Abric O Lyon-Caen D Valeyre JC Piette 2010 Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study Medicine (Baltimore) 89 133 140 10.1097/MD.0b013e3181d5c6b4
16. JJ Braun R Kessler A Constantinesco A Imperiale 2008 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases Eur J Nucl Med Mol Imaging 35 1537 1543 18418595 10.1007/s00259-008-0770-9
17. DA Bradley EE Lower RP Baughman 2006 Diagnosis and management of spinal cord sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 23 58 65 16933471 (Pubitemid 44259210)
18. V Oksanen F Fyhrquist H Somer C Gronhagen-Riska 1985 Angiotensin converting enzyme in cerebrospinal fluid: a new assay Neurology 35 1220 1223 2991815 1:STN:280:DyaL2M3mvVGgug%3D%3D (Pubitemid 15003466)